Product image of Ketorol (Ketorolac Trometamol) supplied by GNH India

Ketorol

Active Ingredient:
Ketorolac Trometamol
Origin:
EU

Ketorol (Ketorolac Trometamol)

Ketorolac trometamol, the active ingredient in Ketorol, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for systemic use. It is indicated for the management of moderate to severe acute pain, including postoperative pain, by reducing inflammation and providing analgesia in adult patients. The drug acts quickly to control pain and is commonly employed in surgical recovery settings.

GNH India supplies Ketorol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Dr. Reddy's Laboratories Romania Srl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ketorolac trometamol is an NSAID that reduces pain and inflammation by inhibiting cyclooxygenase enzymes.

  • Post‑operative pain: provides rapid analgesia to facilitate postoperative recovery.
  • Acute musculoskeletal pain: relieves pain from injuries, strains or sprains.
  • Dental pain: controls severe pain following dental procedures.
  • Renal colic: offers short‑term relief of intense flank pain caused by kidney stones.

How It Works

  • Ketorolac trometamol non‑selectively inhibits cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, blocking the conversion of arachidonic acid to prostaglandins. The resulting decrease in prostaglandin synthesis diminishes peripheral sensitisation, inflammation, and nociceptive signalling, producing analgesic and anti‑inflammatory effects throughout the body.

Side Effects

Ketorolac may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Dyspepsia: indigestion or heartburn.
  • Headache: transient cranial discomfort.
  • Dizziness: occasional light‑headedness.
  • Renal function changes: slight increase in serum creatinine.

Serious or Rare Side Effects

  • Gastrointestinal bleeding or ulcer perforation.
  • Severe skin reactions such as Stevens‑Johnson syndrome.
  • Anaphylaxis: life‑threatening allergic response.
  • Acute renal failure in susceptible individuals.
  • Cardiovascular events including myocardial infarction or stroke.

Precautions & Warnings

When prescribing Ketorolac, clinicians should consider several safety measures.

  • Assess renal function: evaluate baseline creatinine and avoid use in severe renal impairment.
  • Monitor gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding.
  • Check for hypersensitivity: contraindicated in individuals with known NSAID allergy.
  • Use lowest effective dose: limit duration to the shortest period necessary, typically not exceeding 5 days.
  • Pregnancy and lactation: use only if benefits outweigh potential risks and after professional consultation.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Ketorolac can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
  • Concurrent NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity.
  • SSRIs or SNRIs: heightened bleeding tendency.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: may reduce renal perfusion, especially in dehydrated patients.
  • Diuretics: combined use can impair kidney function.
  • Lithium: NSAIDs can raise lithium serum concentrations.
  • Methotrexate: reduced clearance leading to toxicity.

Frequently Asked Questions

Ketorol is prescribed for the short‑term treatment of moderate to severe acute pain, such as post‑operative pain, dental pain, musculoskeletal injuries, and renal colic. It works by reducing inflammation and providing analgesia, helping patients achieve better comfort during recovery.

Ketorolac trometamol blocks both COX‑1 and COX‑2 enzymes, which are essential for prostaglandin production. By lowering prostaglandin levels, the drug diminishes inflammation, reduces peripheral sensitisation, and interrupts pain signalling pathways, resulting in effective analgesia.

The specific dose and treatment duration of Ketorol are determined by the prescribing healthcare professional based on the patient’s condition, age, renal function, and overall risk profile. Only a qualified prescriber should set the regimen.

Ketorol should be used in pregnancy or while breastfeeding only if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers usually avoid it in the third trimester and advise caution, recommending alternative therapies when possible.

To order Ketorol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ketorol is distinguished by its potent analgesic effect, often comparable to moderate‑strength opioids for short‑term use. While many NSAIDs are used for chronic pain, Ketorol is typically limited to a maximum of five days because of its higher risk of gastrointestinal and renal adverse events.

Ketorol should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Ketorol is taken orally, usually with a full glass of water. It may be administered with or without food, but taking it with food can help reduce gastrointestinal discomfort. The exact administration schedule is set by the prescriber.

The most serious risks include gastrointestinal bleeding or ulcer perforation, severe renal impairment, cardiovascular events such as heart attack or stroke, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should be monitored closely for any signs of these complications.

Ketorol is contraindicated in patients with known hypersensitivity to ketorolac or other NSAIDs, active gastrointestinal ulceration, severe renal or hepatic impairment, and those who are in the third trimester of pregnancy. It should also be avoided in individuals taking anticoagulants without careful medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.